                         SEQUENCE LISTING

<110>  Mirkin, et al.
 
<120>  Asymmetric Functionalized Nanoparticles and Methods of Using the 
       Same

<130>  30938/42128A

<150>  US 60/816,103
<151>  2006-06-23

<160>  8     

<170>  PatentIn version 3.3

<210>  1
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  mod_residue
<222>  (1)..(1)
<223>  SH

<400>  1
shaaaaaaaa aaatccttat caatatt                                         27


<210>  2
<211>  44
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  mod_residue
<222>  (40)..(40)
<223>  CH2)3-SH 3

<400>  2
taggaatagt tataagcgta agtcctaacg aaaaaaaaaa chsh                      44


<210>  3
<211>  29
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  mod_residue
<222>  (25)..(25)
<223>  (CH2)3-SH 3

<400>  3
ttataactat tcctaaaaaa aaaaachsh                                       29


<210>  4
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
cgttaggact tacgc                                                      15


<210>  5
<211>  29
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  mod_residue
<222>  (25)..(25)
<223>  (CH2)3-SH 3

<400>  5
taacaataat ccctcaaaaa aaaaachsh                                       29


<210>  6
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
gcgtaagtcc taacg                                                      15


<210>  7
<211>  29
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  mod_residue
<222>  (25)..(25)
<223>  (ch2)3-sh 3

<400>  7
gcgtaagtcc taacgaaaaa aaaaachsh                                       29


<210>  8
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  8
taggaatagt tatta                                                      15


